MUC13 and intrahepatic cholangiocarcinoma: MUC13 was markedly elevated in 93.8% of patients with ICC relative to the corresponding adjacent non-tumor tissues, and the upregulation of MUC13 was closely correlated with reduced OS and PFS of patients with CC.